CytoDyn Announces Plans to Move Forward with Next Stage of Research of CytoFeline


CVM has selected Colorado State University and Dr. Susan VandeWoude, DVM, Associate Dean for Research CVMBS, Professor of Comparative Medicine, DMIP, at Colorado State University to lead the CVM’s continuing research of CytoFeline™, and to conduct these additional efficacy tests. “CytoFeline™ potentially represents an exciting new anti-retroviral therapy for cats with FIV.